CapForce, Inc. (CFOR)
6.02
-0.88
(-12.75%)
USD |
OTCM |
Nov 05, 16:00
CapForce Shareholders Equity (Quarterly) : 74.28M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 74.28M |
| March 31, 2026 | 31.26M |
| December 31, 2025 | 31.86M |
| September 30, 2025 | 10.16M |
| June 30, 2025 | 10.67M |
| March 31, 2025 | 7.054M |
| December 31, 2024 | 7.381M |
| September 30, 2024 | 2.986M |
| June 30, 2024 | -11.67M |
| March 31, 2024 | -10.81M |
| December 31, 2023 | -11.56M |
| September 30, 2023 | 2.677M |
| June 30, 2023 | 6.860M |
| March 31, 2023 | 9.177M |
| December 31, 2022 | 7.576M |
| September 30, 2022 | 13.94M |
| June 30, 2022 | 27.36M |
| March 31, 2022 | 34.17M |
| December 31, 2021 | 41.22M |
| September 30, 2021 | 33.30M |
| June 30, 2021 | 39.74M |
| March 31, 2021 | 46.03M |
| December 31, 2020 | 21.19M |
| September 30, 2020 | 17.08M |
| June 30, 2020 | 18.73M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.08M |
| December 31, 2019 | 4.293M |
| September 30, 2019 | -1.557M |
| June 30, 2019 | 1.827M |
| March 31, 2019 | 4.339M |
| December 31, 2018 | 3.309M |
| September 30, 2018 | 4.030M |
| June 30, 2018 | 6.399M |
| March 31, 2018 | 9.300M |
| December 31, 2017 | 1.401M |
| September 30, 2017 | 3.760M |
| June 30, 2017 | -2.138M |
| March 31, 2017 | 0.5541M |
| December 31, 2016 | 3.168M |
| September 30, 2016 | 3.275M |
| June 30, 2016 | 7.944M |
| March 31, 2016 | 3.254M |
| December 31, 2015 | 7.491M |
| September 30, 2015 | 11.94M |
| June 30, 2015 | 8.828M |
| March 31, 2015 | -4.078M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | 12.60M |
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 14.35B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -397.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 87.68M |
| Total Liabilities (Quarterly) | 13.40M |
| Debt to Equity Ratio | 0.0264 |
| Current Ratio | 4.273 |
| Net Debt Paydown Yield | 0.00% |